But it is an uphill battle
The revenues generated from these GLP-1 Agonists have been determined through annual reports and secondary sources (including paid databases) The products were mapped according to the market segments
Semaglutide Semaglutide is a GLP-1 medication that helps reduce appetite, curb cravings, and improve metabolic function to support steady, sustainable weight loss
Despite this potential, given the known long-term benefit of lowering hemoglobin A1c in preventing DR progression, there does not appear to be any contraindication to initiating GLP-1/GIP agonist therapy with appropriate ocular monitoring
& Takada, M
Gastaldelli A, Cusi K, Fernndez Land L, Bray R, Brouwers B, Rodrguez